223 related articles for article (PubMed ID: 20702603)
1. Image-guided breast tumor therapy using a small interfering RNA nanodrug.
Kumar M; Yigit M; Dai G; Moore A; Medarova Z
Cancer Res; 2010 Oct; 70(19):7553-61. PubMed ID: 20702603
[TBL] [Abstract][Full Text] [Related]
2. Sequence-dependent combination therapy with doxorubicin and a survivin-specific small interfering RNA nanodrug demonstrates efficacy in models of adenocarcinoma.
Ghosh SK; Yigit MV; Uchida M; Ross AW; Barteneva N; Moore A; Medarova Z
Int J Cancer; 2014 Apr; 134(7):1758-66. PubMed ID: 24114765
[TBL] [Abstract][Full Text] [Related]
3. Development and application of a dual-purpose nanoparticle platform for delivery and imaging of siRNA in tumors.
Medarova Z; Kumar M; Ng SW; Moore A
Methods Mol Biol; 2009; 555():1-13. PubMed ID: 19495684
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging.
Medarova Z; Rashkovetsky L; Pantazopoulos P; Moore A
Cancer Res; 2009 Feb; 69(3):1182-9. PubMed ID: 19141648
[TBL] [Abstract][Full Text] [Related]
5. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
6. Survivin stable knockdown by siRNA inhibits tumor cell growth and angiogenesis in breast and cervical cancers.
Li QX; Zhao J; Liu JY; Jia LT; Huang HY; Xu YM; Zhang Y; Zhang R; Wang CJ; Yao LB; Chen SY; Yang AG
Cancer Biol Ther; 2006 Jul; 5(7):860-6. PubMed ID: 16861916
[TBL] [Abstract][Full Text] [Related]
7. Stealth magnetic nanocarriers of siRNA as platform for breast cancer theranostics.
Bruniaux J; Djemaa SB; Hervé-Aubert K; Marchais H; Chourpa I; David S
Int J Pharm; 2017 Nov; 532(2):660-668. PubMed ID: 28506802
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional Superparamagnetic Nanoparticles: From Synthesis to siRNA Delivery.
Arami S; Mahdavi M; Rashidi MR; Fathi M; Hejazi MS; Samadi N
Curr Pharm Des; 2017; 23(16):2400-2409. PubMed ID: 27799034
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
[TBL] [Abstract][Full Text] [Related]
10. Superparamagnetic iron oxide nanoparticles mediated (131)I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice.
Chen J; Zhu S; Tong L; Li J; Chen F; Han Y; Zhao M; Xiong W
BMC Cancer; 2014 Feb; 14():114. PubMed ID: 24555445
[TBL] [Abstract][Full Text] [Related]
11. Receptor-targeted nanoparticles for in vivo imaging of breast cancer.
Yang L; Peng XH; Wang YA; Wang X; Cao Z; Ni C; Karna P; Zhang X; Wood WC; Gao X; Nie S; Mao H
Clin Cancer Res; 2009 Jul; 15(14):4722-32. PubMed ID: 19584158
[TBL] [Abstract][Full Text] [Related]
12. Magnetic nanocarriers for the specific delivery of siRNA: Contribution of breast cancer cells active targeting for down-regulation efficiency.
Bruniaux J; Allard-Vannier E; Aubrey N; Lakhrif Z; Ben Djemaa S; Eljack S; Marchais H; Hervé-Aubert K; Chourpa I; David S
Int J Pharm; 2019 Oct; 569():118572. PubMed ID: 31352052
[TBL] [Abstract][Full Text] [Related]
13. Novel Survivin-Targeted Small Interfering RNA Delivered by Nanoparticles.
Feng C; Wang T; Zhang Y; Qu K; Tang S
Am J Med Sci; 2017 Nov; 354(5):506-512. PubMed ID: 29173363
[TBL] [Abstract][Full Text] [Related]
14. Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors.
Hathaway HJ; Butler KS; Adolphi NL; Lovato DM; Belfon R; Fegan D; Monson TC; Trujillo JE; Tessier TE; Bryant HC; Huber DL; Larson RS; Flynn ER
Breast Cancer Res; 2011 Nov; 13(5):R108. PubMed ID: 22035507
[TBL] [Abstract][Full Text] [Related]
15. All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery.
Lee JH; Lee K; Moon SH; Lee Y; Park TG; Cheon J
Angew Chem Int Ed Engl; 2009; 48(23):4174-9. PubMed ID: 19408274
[TBL] [Abstract][Full Text] [Related]
16. A reduction and pH dual-sensitive nanodrug for targeted theranostics in hepatocellular carcinoma.
Cai M; Li B; Lin L; Huang J; An Y; Huang W; Zhou Z; Wang Y; Shuai X; Zhu K
Biomater Sci; 2020 Jun; 8(12):3485-3499. PubMed ID: 32432234
[TBL] [Abstract][Full Text] [Related]
17. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
[TBL] [Abstract][Full Text] [Related]
18. Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo.
Li Z; Yin PH; Yang SS; Li QY; Chang T; Fang L; Shi LX; Fang GE
Mol Med Rep; 2013 Apr; 7(4):1215-22. PubMed ID: 23404494
[TBL] [Abstract][Full Text] [Related]
19. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]